Physician

Jesus Maria Ramirez, M.D.

According to 2025 Medicare claims, Jesus Ramirez, M.D. (NPI: 1871522201) practices pulmonary disease in the Panama City-Panama City Beach, FL market, with the plurality of this provider's patient population coming from Bay, FL. This provider's primary affiliated billing organization is JESUS M. RAMIREZ, MD PA (NPI: 1861613762; TIN: 202371276) and primary practice location at 32401-3642.

Ramirez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,550 traditional Medicare patients, billed 8,035 HCPCS/CPT codes, and received $565,157 in Medicare payments. The top billing code was 99233 (Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes). Part D data shows 2,658 prescription claims across 585 beneficiaries totaling $1,742,531 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 8,963 claims. Open Payments data shows 80 records totaling $1,616. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $297,010 to $1,742,531. For DME billing, reported payments moved from a lower plateau to a higher plateau, from $324,624 to $393,129.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	946	4,932	$465,721
2016	1,058	5,961	$497,163
2017	1,208	6,171	$496,337
2018	1,283	7,169	$550,896
2019	1,239	5,308	$446,322
2020	1,564	7,506	$628,621
2021	1,655	10,297	$790,109
2022	1,528	7,861	$557,472
2023	1,545	8,341	$606,963
2024	1,550	8,035	$565,157

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	258	1,755	$297,010
2016	232	1,456	$235,830
2017	270	1,354	$283,056
2018	324	1,370	$390,903
2019	333	1,380	$529,810
2020	350	1,385	$572,531
2021	331	1,272	$595,242
2022	405	1,650	$941,369
2023	519	2,221	$1,584,871
2024	585	2,658	$1,742,531

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	1,734	4,384	$334,581
2016	2,019	4,903	$222,213
2017	2,612	5,866	$196,419
2018	3,268	8,168	$314,608
2019	3,809	9,286	$359,459
2020	4,545	11,802	$586,409
2021	4,166	10,975	$566,973
2022	3,834	9,784	$477,293
2023	3,753	9,358	$484,067
2024	3,573	8,963	$420,416

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	368	1,037	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	773	1,276	$88
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	444	626	$62
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	352	2,623	$60
94060	Test to measure expiratory airflow and volume changes before and after medication administration	312	317	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	510	29,850	$627,060
Prolastin C	Alpha-1-Proteinase Inhibitor	36	952	$417,346
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	193	9,120	$192,751
Opsumit	Macitentan	11	330	$136,218
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	112	5,700	$86,457

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	109	672	$52,371
A7030	Full face mask used with positive airway pressure device, each	N	206	483	$40,065
A7032	Cushion for use on nasal mask interface, replacement only, each	N	184	408	$36,061
A7031	Face mask interface, replacement for full face mask, each	N	196	469	$35,793
A7034	Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strap	N	286	648	$32,558

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	80	$1,616	Inspire Medical Systems, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jesus Maria Ramirez, M.D.?

Tedicare shows public-source Medicare data for Jesus Maria Ramirez, M.D. (NPI 1871522201), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jesus Maria Ramirez, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jesus Maria Ramirez, M.D.?

Jesus Maria Ramirez, M.D. is linked to JESUS M. RAMIREZ, MD PA (billing NPI 1861613762) in the available physician profile data.

Does Jesus Maria Ramirez, M.D. have Open Payments data?

Jesus Maria Ramirez, M.D. has 80 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.